Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Douglas Merkel to Breast Neoplasms

This is a "connection" page, showing publications Douglas Merkel has written about Breast Neoplasms.

 
Connection Strength
 
 
 
0.424
 
  1. Sener SF, Cady B, Merkel D. Primary factor in declining breast cancer mortality rates: early detection or adjuvant therapy? Cancer Pract. 2002 Jan-Feb; 10(1):45-7.
    View in: PubMed
    Score: 0.086
  2. O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Nath A, Huo D, Fleming GF, Ingle JN, Abramson VG, Morrow PK, Storniolo AM, Forero A, Van Poznak C, Liu MC, Chang JC, Merkel DE, Peppercorn JM, Rugo HS, Dees EC, Hahn OM, Hoffman PC, Rosner GL, Huang RS, Ratain MJ, Cox N, Olopade OI, Wolff AC, Dolan ME, Nanda R. Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
    View in: PubMed
    Score: 0.077
  3. Sener SF, Imperato JP, Khandekar JD, Ragin A, Beck J, Merkel DE. Achieving local control for inflammatory carcinoma of the breast. Surg Gynecol Obstet. 1992 Aug; 175(2):141-4.
    View in: PubMed
    Score: 0.045
  4. Menas P, Merkel D, Hui W, Lawton J, Harper A, Carro G. Incidence and management of arthralgias in breast cancer patients treated with aromatase inhibitors in an outpatient oncology clinic. J Oncol Pharm Pract. 2012 Dec; 18(4):387-93.
    View in: PubMed
    Score: 0.043
  5. Garcia SF, Rosenbloom SK, Beaumont JL, Merkel D, Von Roenn JH, Rao D, Cella D. Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16). Value Health. 2012 Jan; 15(1):183-90.
    View in: PubMed
    Score: 0.042
  6. Winchester DJ, Duda RB, August CZ, Goldschmidt RA, Wruck DM, Rademaker AW, Winchester DP, Merkel DE. The importance of DNA flow cytometry in node-negative breast cancer. Arch Surg. 1990 Jul; 125(7):886-9.
    View in: PubMed
    Score: 0.039
  7. Merkel DE, Osborne CK. Prognostic factors in breast cancer. Hematol Oncol Clin North Am. 1989 Dec; 3(4):641-52.
    View in: PubMed
    Score: 0.037
  8. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, Goodman MT, Giuliano AE, Karanja N, McAndrew P, Hudis C, Butler J, Merkel D, Kristal A, Caan B, Michaelson R, Vinciguerra V, Del Prete S, Winkler M, Hall R, Simon M, Winters BL, Elashoff RM. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst. 2006 Dec 20; 98(24):1767-76.
    View in: PubMed
    Score: 0.030
  9. Tedesco KL, Thor AD, Johnson DH, Shyr Y, Blum KA, Goldstein LJ, Gradishar WJ, Nicholson BP, Merkel DE, Murrey D, Edgerton S, Sledge GW. Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial. J Clin Oncol. 2004 Mar 15; 22(6):1071-7.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.